GYRE

NASDAQStock

Gyre Therapeutics, Inc.

$7.56-0.25 (-3.15%)

52-Week Range

$6.41

$12.28

Key Stats

Market Cap

687.1M

P/E Ratio

251.98

Dividend Yield

—

Beta

6.92

Volume

123.2K

Avg Volume

139.4K

Performance

-0.19%

+3.51%

-1.20%

YTD

+14.61%

-35.55%

+15.97%

Price Chart

ETF Exposure

GYRE is held by 37 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
EES	WisdomTree U.S. SmallCap Fund	0.03%	20,183	$152K	$620.3M	0.38%
OMFS	Invesco Russell 2000 Dynamic Multifactor ETF	0.01%	2,632	$22K	$247.9M	0.39%
IWO	iShares Russell 2000 Growth ETF	0.01%	96,044	$800K	$12.36B	0.24%
VTWG	Vanguard Russell 2000 Growth ETF	0.01%	10,793	$87K	$1.50B	0.06%
SCHA	Schwab U.S. Small-Cap ETF	0.00%	101,383	$825K	$19.55B	0.04%
XRS2.DE	Xtrackers Russell 2000 UCITS ETF 1C	0.00%	11,287	$77K	$2.11B	0.30%
XRSU.L	Xtrackers Russell 2000 UCITS ETF 1C	0.00%	11,287	$88K	$2.43B	0.30%
SC0K.DE	Invesco Russell 2000 UCITS ETF	0.00%	0	$0	$189.7M	0.45%
IWM	iShares Russell 2000 ETF	0.00%	239,587	$2.0M	$69.44B	0.19%
RSSL	Global X - Russell 2000 ETF	0.00%	5,385	$44K	$1.33B	0.08%
VTWO	Vanguard Russell 2000 ETF	0.00%	56,420	$456K	$14.50B	0.06%
XSU.TO	iShares U.S. Small Cap Index ETF (CAD-Hedged)	0.00%	239,587	$19K	$677.7M	0.36%
R2SC.L	State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc)	0.00%	14,864	$91K	$3.73B	0.30%
URTY	ProShares - UltraPro Russell2000	0.00%	711	$6K	$284.9M	1.08%
UWM	ProShares - Ultra Russell2000	0.00%	700	$5K	$264.2M	1.07%
VXF	Vanguard Extended Market ETF	0.00%	233,123	$1.9M	$84.10B	0.05%
AVSC	Avantis U.S. Small Cap Equity ETF	0.00%	1,907	$15K	$2.36B	0.25%
SMMD	iShares Russell 2500 ETF	0.00%	3,588	$30K	$2.28B	0.23%
DFAS	Dimensional - US Small Cap ETF	0.00%	320	$2K	$12.65B	0.26%
HDG	ProShares - Hedge Replication ETF	0.00%	13	$101	$23.2M	0.95%
ITDB	iShares LifePath Target Date 2030 ETF	0.00%	1	$7	$60.6M	0.09%
ITDC	iShares LifePath Target Date 2035 ETF	0.00%	3	$23	$80.3M	0.10%
ITDD	iShares LifePath Target Date 2040 ETF	0.00%	5	$39	$80.4M	0.11%
ITDE	iShares LifePath Target Date 2045 ETF	0.00%	5	$45	$63.0M	0.11%
ITDF	iShares LifePath Target Date 2050 ETF	0.00%	6	$53	$57.9M	0.11%
ITDG	iShares LifePath Target Date 2055 ETF	0.00%	5	$44	$42.1M	0.12%
ITDH	iShares LifePath Target Date 2060 ETF	0.00%	4	$29	$28.3M	0.12%
ITDI	iShares LifePath Target Date 2065 ETF	0.00%	3	$22	$21.0M	0.12%
ITDJ	iShares LifePath Target Date 2070 ETF	0.00%	1	$9	$9.3M	0.12%
SCHB	Schwab U.S. Broad Market ETF	0.00%	18,000	$148K	$37.50B	0.03%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	76	$397	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	2,729	$14K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	13	$68	$337.7M	0.32%
VTHR	Vanguard Russell 3000 ETF	0.00%	805	$7K	$5.50B	0.06%
VTI	Vanguard Total Stock Market ETF	0.00%	727,501	$5.9M	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	8,173	$43K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	704	$4K	$1.29B	0.17%

About GYRE ETF Exposure

Gyre Therapeutics, Inc. (GYRE) is held by 37 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 687.1M, GYRE is a widely held institutional stock. The stock currently trades at $7.56. Investors can gain exposure to GYRE through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold GYRE, sorted by portfolio weight.